(Q38032999)

27 August 2017

1 reference

title

Clozapine: an atypical neuroleptic (English)

1 reference

27 August 2017

Bruhwyler J

1

1 reference

27 August 2017

Chleide E

series ordinal

2

1 reference

27 August 2017

Mercier M

series ordinal

3

1 reference

27 August 2017

publication date

1 January 1990

1 reference

Neuroscience & Biobehavioral Reviews

27 August 2017

published in

1 reference

27 August 2017

volume

14

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

357-363

1 reference

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine-induced agranulocytosis: a situation report up to August 1976.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine and haloperidol in the amygdaloid complex: differential effects on dopamine transmission with long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine effects on responding maintained under shock presentation and shock termination schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effects of d-amphetamine, chlordiazepoxide and promazine on responding of squirrel monkeys maintained under fixed-interval schedules of food presentation and stimulus-shock termination

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effects of clozapine, haloperidol and thiothixene on schedule-controlled responding and schedule-induced eating and drinking of rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effects of chlorpromazine and three metabolites on behavioral responses in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Pre- and postsynaptic striatal dopamine receptors: differential sensitivity to apomorphine inhibition of [3H]dopamine and [14C]GABA release in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effects of clozapine, chlorpromazine and diazepam upon adjunctive and schedule controlled behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Use of DRL in differentiating anxiolytic and neuroleptic properties of CNS drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

A comparison of clozapine, chlorpromazine, and thioridazine upon DRL performance in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effects of conformationally restricted 4-piperazinyl-10H-thienobenzodiazepine neuroleptics on central dopaminergic and cholinergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine in the treatment of newly admitted schizophrenic patients. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Drug effects on the behavior of animals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Evidence for dopamine receptors mediating sedation in the mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Time course of chronic haloperidol and clozapine upon operant rate and duration.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

An examination of methodological refinements, clozapine and fluphenazine in the anhedonia paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine--a serotonin antagonist?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effects of clozapine and chlorpromazine upon operant response measures in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Discriminative stimulus properties of clozapine and chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Basic biology of clozapine: electrophysiological and neuroendocrinological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Acetylcholine synthesis in rat brain: Dissimilar effects of clozapine and chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

3H-Clozapine binding to rat brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

The history of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

ADVERSE REACTIONS TO PHENOTHIAZINES.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

11-Amino-5H-dibenzo[b, e]-1, 4-diazepine. 10. Mitteilung über siebengliedrige Heterocyclen

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Agranulocytosis during treatment with chlozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of α1-noradrenergic receptors demonstrated by in vivo voltammetry

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Who should receive clozapine?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Minireview A systematic study of the pharmacological activities of dopamine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine in the treatment of tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Interactions of neuroleptic compounds at alpha 2-adrenergic receptor affinity states in bovine caudate nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effects of clozapine on fixed-consecutive-number responding in rats: a comparison to other neuroleptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Akathisia: a side effect to be remembered.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

“Classical” and “atypical” antipsychotic drugs: Differential antagonism of amphetamine- and apomorphine-induced alterations of spontaneous neuronal activity in the neostriatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Neostriatal and mesolimbic neurons: dose-dependent effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

The effects of tranquillizing drugs on timing behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of γ-aminobutyric acid, glutamate or serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Antagonism of fenfluramine-induced hyperthermia: A measure of central serotonin inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Biphasic and opposite effects of dopamine and apomorphine on endogenous GABA release in the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Serotonin-dopamine interactions in the nigrostriatal system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

Effects of clozapine, chlorpromazine and haloperidol on schedule-controlled behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980058-2

7 January 2021

10.1016/S0149-7634(05)80058-2

Identifiers

DOI

1 reference

27 August 2017

1 reference